Tami Tillotson Martin, Senior V.P, Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 8,000 shares at $27.91 ($223K) on 2024-01-10, disclosed to the SEC on 2024-01-12.
Scheduled sale ($223k) by Senior V.P, Regulatory Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SUPN | SELL | 2022-08-23 | $360K | — | Filing → |
| SUPN | SELL | 2022-08-05 | $330K | — | Filing → |
| SUPN | SELL | 2021-04-14 | $387K | — | Filing → |